Pharnext amends the protocol of the international pivotal Phase 3 trials of PXT3003 for CMT1A
Pharnext to Present at 7th Annual CEC Capital Summit
PXT3003: Featured at the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) 2017 Annual Meeting
PXT3003: DSMB recommends continuing the ongoing Phase 3 Trial of PXT3003 for CMT1A
Pharnext to present at Rodman & Renshaw 19th Annual Global Investment Conference
Pharnext to hold its first satellite symposium on CMT1A at Neuromuscular Days in Marseille
PXT864: Data presented at the Alzheimer's Association International Conference 2017
PXT3003: Status of ongoing Phase 3 trial to be featured at the 2017 Peripheral Nerve Society Meeting
Pharnext to showcase PLEOTHERAPY™ platform at Drug Repositioning, Repurposing and Rescue Conference
Strategic partnership with Tasly, a leading Chinese pharmaceutical group
Pharnext reports year end 2016 financial results
Pharnext confirms its continued eligibility to the PEA-PME
Reclassification of historical investor’s shares - Strengthening the position of core shareholders
PXT864: New synergy data presented at AD/PD™ 2017 Conference in Vienna, Austria
PXT3003: initiation of Phase 3 extension study PLEO-CMT-FU for CMT1A
R&D agreement with Galapagos to generate a new pipeline of synergistic drug combinations
Pharnext to present at 2017 BIO & CEO Investor Conference in New York, USA
Pharnext evaluates the clinical scale Charcot-Marie-Tooth Neuropathy Score
Pharnext winner of the Best Life-Sciences IPO France 2016 Award
Pharnext to Attend January Investor Conferences
Amendment to the liquidity contract and annual update
PXT3003: PLEO-CMT Phase 3 Trial enrollment completed
PXT864: Positive Phase 2 data in Alzheimer's disease présented at CTAD in San Diego, USA
PXT864: Phase 2 data in Alzheimer's disease will be featured at CTAD in San Diego, USA
PXT3003: DSMB recommends continuing the PLEO-CMT study
Pharnext to attend Jefferies 2016 Healthcare Conference in London, UK
Pharnext announces first half 2016 results
Pharnext supports the first CMT summit organized by HNF
Pharnext confirms its support to the HNF on CMT
PXT3003 featured at 2016 International CMT meeting
Page 1 of 2
